THERMO FISHER SCIENTIFIC INC CEDEAR EAC 22 REP 1(USD)TT

THERMO FISHER SCIENTIFIC INC CEDEAR EAC 22 REP 1(USD)

28.500USDD
+1.500+5.56%
At close at Oct 1, 2024, 14:49 GMT
USD
No trades
See on Supercharts
Market capitalization
‪200.59 B‬USD
0.674USD
‪5.63 B‬USD
‪38.09 B‬USD
Beta (1Y)
0.03

About Thermo Fisher Scientific Inc


CEO
Marc N. Casper
Headquarters
Waltham
Founded
1960
ISIN
ARBCOM4601F7
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines. The Analytical Instruments segment offers instruments and the supporting consumables, software, and services that are used for a range of applications. The Specialty Diagnostics segment includes a wide range of diagnostic test kits, reagents, culture media, instruments, and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment is involved in virtually everything needed for the laboratory. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Performance
‪10.0%‬
‪11.6%‬
‪13.2%‬
‪14.8%‬
‪16.4%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪10.00 B‬‬
‪‪20.00 B‬‬
‪‪30.00 B‬‬
‪‪40.00 B‬‬
Debt
Free cash flow
Cash & equivalents

No news here

Looks like there's nothing to report right now

See all ideas 

Displays a symbol's price movements over previous years to identify recurring trends.
US883556CM2
THERMO FISH. 21/41
Yield to maturity
6.32%
Maturity date
Oct 15, 2041
TMO4530434
Thermo Fisher Scientific Inc. 4.1% 15-AUG-2047
Yield to maturity
5.90%
Maturity date
Aug 15, 2047
TMO4078058
Thermo Fisher Scientific Inc. 5.3% 01-FEB-2044
Yield to maturity
5.52%
Maturity date
Feb 1, 2044
TMO5630948
Thermo Fisher Scientific Inc. 5.404% 10-AUG-2043
Yield to maturity
5.41%
Maturity date
Aug 10, 2043
XS205855734
THERMO FISH. 19/49
Yield to maturity
5.08%
Maturity date
Oct 1, 2049
US883556CL4
THERMO FISH. 21/31
Yield to maturity
5.04%
Maturity date
Oct 15, 2031
T
XS236641554
TH.FISHER SC 21/51
Yield to maturity
5.03%
Maturity date
Oct 18, 2051
TMO5630927
Thermo Fisher Scientific Inc. 5.086% 10-AUG-2033
Yield to maturity
4.96%
Maturity date
Aug 10, 2033
TMO5710956
Thermo Fisher Scientific Inc. 5.2% 31-JAN-2034
Yield to maturity
4.95%
Maturity date
Jan 31, 2034
T
XS236641520
TH.FISHER SC 21/41
Yield to maturity
4.86%
Maturity date
Oct 18, 2041
US883556CU4
THERMO FISH. 22/32
Yield to maturity
4.85%
Maturity date
Nov 21, 2032

See all TMOD bonds